The Orphan Nuclear Receptor Nur77 Is a Determinant of Myofiber Size and Muscle Mass in Mice

REFERENCES

• von Haehling S, Anker SD. 2012. Cachexia as major underestimated unmet medical need: facts and numbers. Int J Cardiol 161:121–123. http://dx.doi.org/10.1016/j.ijcard.2012.09.213.
   PubMedGoogle Scholar
• Srikanthan P, Hevener AL, Karlamangla AS. 2010. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One 5:e10805. http://dx.doi.org/10.1371/journal.pone.0010805.
   PubMed Web of Science ®Google Scholar
• Srikanthan P, Karlamangla AS. 2011. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 96:2898–2903. http://dx.doi.org/10.1210/jc.2011-0435.
   PubMed Web of Science ®Google Scholar
• Bauman WA, Spungen AM. 1994. Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: a model of premature aging. Metabolism 43:749–756. http://dx.doi.org/10.1016/0026-0495(94)90126-0.
   PubMed Web of Science ®Google Scholar
• Ryall JG, Church JE, Lynch GS. 2010. Novel role for ss-adrenergic signalling in skeletal muscle growth, development and regeneration. Clin Exp Pharmacol Physiol 37:397–401. http://dx.doi.org/10.1111/j.1440-1681.2009.05312.x.
   PubMed Web of Science ®Google Scholar
• Egerman MA, Glass DJ. 2014. Signaling pathways controlling skeletal muscle mass. Crit Rev Biochem Mol Biol 49:59–68. http://dx.doi.org/10.3109/10409238.2013.857291.
   PubMed Web of Science ®Google Scholar
• Gundersen K. 2011. Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise. Biol Rev Camb Philos Soc 86:564–600. http://dx.doi.org/10.1111/j.1469-185X.2010.00161.x.
   PubMed Web of Science ®Google Scholar
• Duchene S, Audouin E, Crochet S, Duclos MJ, Dupont J, Tesseraud S. 2008. Involvement of the ERK1/2 MAPK pathway in insulin-induced S6K1 activation in avian cells. Domest Anim Endocrinol 34:63–73. http://dx.doi.org/10.1016/j.domaniend.2006.11.001.
   PubMedGoogle Scholar
• Haddad F, Adams GR. 2004. Inhibition of MAP/ERK kinase prevents IGF-I-induced hypertrophy in rat muscles. J Appl Physiol 96:203–210. http://dx.doi.org/10.1152/japplphysiol.00856.2003.
   PubMed Web of Science ®Google Scholar
• Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, Zierath JR. 2000. Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. Involvement off the mitogen- and stress-activated protein kinase 1. J Biol Chem 275:1457–1462. http://dx.doi.org/10.1074/jbc.275.2.1457.
   PubMed Web of Science ®Google Scholar
• Egan B, Carson BP, Garcia-Roves PM, Chibalin AV, Sarsfield FM, Barron N, McCaffrey N, Moyna NM, Zierath JR, O'Gorman DJ. 2010. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor γ coactivator-1α mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588:1779–1790. http://dx.doi.org/10.1113/jphysiol.2010.188011.
   PubMed Web of Science ®Google Scholar
• Ruas JL, White JP, Rao RR, Kleiner S, Brannan KT, Harrison BC, Greene NP, Wu J, Estall JL, Irving BA, Lanza IR, Rasbach KA, Okutsu M, Nair KS, Yan Z, Leinwand LA, Spiegelman BM. 2012. A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell 151:1319–1331. http://dx.doi.org/10.1016/j.cell.2012.10.050.
   PubMed Web of Science ®Google Scholar
• Ruegg MA, Glass DJ. 2011. Molecular mechanisms and treatment options for muscle wasting diseases. Annu Rev Pharmacol Toxicol 51:373–395. http://dx.doi.org/10.1146/annurev-pharmtox-010510-100537.
   PubMed Web of Science ®Google Scholar
• McFarlane C, Plummer E, Thomas M, Hennebry A, Ashby M, Ashby M, Ling N, Smith H, Sharma M, Kambadur R. 2006. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-κB-independent, FoxO1-dependent mechanism. J Cell Physiol 209:501–514. http://dx.doi.org/10.1002/jcp.20757.
   PubMed Web of Science ®Google Scholar
• Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. 2004. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395–403. http://dx.doi.org/10.1016/S1097-2765(04)00211-4.
   PubMed Web of Science ®Google Scholar
• Helbling JC, Minni AM, Pallet V, Moisan MP. 2014. Stress and glucocorticoid regulation of NR4A genes in mice. J Neurosci Res 92:825–834. http://dx.doi.org/10.1002/jnr.23366.
   PubMed Web of Science ®Google Scholar
• Maxwell MA, Muscat GE. 2006. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal 4:e002. http://dx.doi.org/10.1621/nrs.04002.
   PubMedGoogle Scholar
• Chao LC, Zhang Z, Pei L, Saito T, Tontonoz P, Pilch PF. 2007. Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol Endocrinol 21:2152–2163. http://dx.doi.org/10.1210/me.2007-0169.
   PubMedGoogle Scholar
• Mahoney DJ, Parise G, Melov S, Safdar A, Tarnopolsky MA. 2005. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J 19:1498–1500. http://dx.doi.org/10.1096/fj.04-3149fje.
   PubMed Web of Science ®Google Scholar
• Chao LC, Wroblewski K, Zhang Z, Pei L, Vergnes L, Ilkayeva OR, Ding SY, Reue K, Watt MJ, Newgard CB, Pilch PF, Hevener AL, Tontonoz P. 2009. Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes 58:2788–2796. http://dx.doi.org/10.2337/db09-0763.
   PubMed Web of Science ®Google Scholar
• Chao LC, Wroblewski K, Ilkayeva OR, Stevens RD, Bain J, Meyer GA, Schenk S, Martinez L, Vergnes L, Narkar VA, Drew BG, Hong C, Boyadjian R, Hevener AL, Evans RM, Reue K, Spencer MJ, Newgard CB, Tontonoz P. 2012. Skeletal muscle Nur77 expression enhances oxidative metabolism and substrate utilization. J Lipid Res 53:2610–2619. http://dx.doi.org/10.1194/jlr.M029355.
   PubMed Web of Science ®Google Scholar
• Pearen MA, Eriksson NA, Fitzsimmons RL, Goode JM, Martel N, Andrikopoulos S, Muscat GE. 2012. The nuclear receptor, Nor-1, markedly increases type II oxidative muscle fibers and resistance to fatigue. Mol Endocrinol 26:372–384. http://dx.doi.org/10.1210/me.2011-1274.
   PubMedGoogle Scholar
• Sekiya T, Kashiwagi I, Yoshida R, Fukaya T, Morita R, Kimura A, Ichinose H, Metzger D, Chambon P, Yoshimura A. 2013. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat Immunol 14:230–237. http://dx.doi.org/10.1038/ni.2520.
   PubMed Web of Science ®Google Scholar
• Ponnio T, Burton Q, Pereira FA, Wu DK, Conneely OM. 2002. The nuclear receptor Nor-1 is essential for proliferation of the semicircular canals of the mouse inner ear. Mol Cell Biol 22:935–945. http://dx.doi.org/10.1128/MCB.22.3.935-945.2002.
   PubMedGoogle Scholar
• Chao LC, Soto E, Hong C, Ito A, Pei L, Chawla A, Conneely OM, Tangirala RK, Evans RM, Tontonoz P. 2013. Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in mice. J Lipid Res 54:806–815. http://dx.doi.org/10.1194/jlr.M034157.
   PubMedGoogle Scholar
• Rando TA, Blau HM. 1994. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125:1275–1287. http://dx.doi.org/10.1083/jcb.125.6.1275.
   PubMed Web of Science ®Google Scholar
• Frey N, Frank D, Lippl S, Kuhn C, Kogler H, Barrientos T, Rohr C, Will R, Muller OJ, Weiler H, Bassel-Duby R, Katus HA, Olson EN. 2008. Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation. J Clin Invest 118:3598–3608. http://dx.doi.org/10.1172/JCI36277.
   PubMed Web of Science ®Google Scholar
• Lach-Trifilieff E, Minetti GC, Sheppard K, Ibebunjo C, Feige JN, Hartmann S, Brachat S, Rivet H, Koelbing C, Morvan F, Hatakeyama S, Glass DJ. 2014. An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Mol Cell Biol 34:606–618. http://dx.doi.org/10.1128/MCB.01307-13.
   PubMed Web of Science ®Google Scholar
• Pearen MA, Goode JM, Fitzsimmons RL, Eriksson NA, Thomas GP, Cowin GJ, Wang SC, Tuong ZK, Muscat GE. 2013. Transgenic muscle-specific Nor-1 expression regulates multiple pathways that effect adiposity, metabolism, and endurance. Mol Endocrinol 27:1897–1917. http://dx.doi.org/10.1210/me.2013-1205.
   PubMedGoogle Scholar
• Pei L, Waki H, Vaitheesvaran B, Wilpitz DC, Kurland IJ, Tontonoz P. 2006. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 12:1048–1055. http://dx.doi.org/10.1038/nm1471.
   PubMed Web of Science ®Google Scholar
• Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N. 2001. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27:195–200. http://dx.doi.org/10.1038/84839.
   PubMed Web of Science ®Google Scholar
• Stewart CE, Pell JM. 2010. Point:counterpoint: IGF is/is not the major physiological regulator of muscle mass. Point: IGF is the major physiological regulator of muscle mass. J Appl Physiol 108:1820–1824. http://dx.doi.org/10.1152/japplphysiol.01246.2009.
   PubMedGoogle Scholar
• Shavlakadze T, Davies M, White JD, Grounds MD. 2004. Early regeneration of whole skeletal muscle grafts is unaffected by overexpression of IGF-1 in MLC/mIGF-1 transgenic mice. J Histochem Cytochem 52:873–883. http://dx.doi.org/10.1369/jhc.3A6177.2004.
   PubMedGoogle Scholar
• Kardon G, Heanue TA, Tabin CJ. 2002. Pax3 and Dach2 positive regulation in the developing somite. Dev Dyn 224:350–355. http://dx.doi.org/10.1002/dvdy.10107.
   PubMedGoogle Scholar
• Baehr LM, Furlow JD, Bodine SC. 2011. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J Physiol 589:4759–4776. http://dx.doi.org/10.1113/jphysiol.2011.212845.
   PubMedGoogle Scholar
• Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704–1708. http://dx.doi.org/10.1126/science.1065874.
   PubMed Web of Science ®Google Scholar
• Labeit S, Kohl CH, Witt CC, Labeit D, Jung J, Granzier H. 2010. Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1 as indicated by hindlimb suspension studies on MuRF1-KO mice. J Biomed Biotechnol 2010:693741. http://dx.doi.org/10.1155/2010/693741.
   PubMedGoogle Scholar
• Bhatnagar S, Mittal A, Gupta SK, Kumar A. 2012. TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases. J Cell Physiol 227:1042–1051. http://dx.doi.org/10.1002/jcp.22821.
   PubMedGoogle Scholar
• McPherron AC, Lawler AM, Lee SJ. 1997. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83–90. http://dx.doi.org/10.1038/387083a0.
   PubMed Web of Science ®Google Scholar
• Shi J, Luo L, Eash J, Ibebunjo C, Glass DJ. 2011. The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling. Dev Cell 21:835–847. http://dx.doi.org/10.1016/j.devcel.2011.09.011.
   PubMedGoogle Scholar
• Ye J, Zhang Y, Xu J, Zhang Q, Zhu D. 2007. FBXO40, a gene encoding a novel muscle-specific F-box protein, is upregulated in denervation-related muscle atrophy. Gene 404:53–60. http://dx.doi.org/10.1016/j.gene.2007.08.020.
   PubMedGoogle Scholar
• Gomes AV, Waddell DS, Siu R, Stein M, Dewey S, Furlow JD, Bodine SC. 2012. Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation. FASEB J 26:2986–2999. http://dx.doi.org/10.1096/fj.12-204495.
   PubMedGoogle Scholar
• Ovcharenko I, Nobrega MA, Loots GG, Stubbs L. 2004. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 32:W280–W286. http://dx.doi.org/10.1093/nar/gkh355.
   PubMed Web of Science ®Google Scholar
• Dinchuk JE, Cao C, Huang F, Reeves KA, Wang J, Myers F, Cantor GH, Zhou X, Attar RM, Gottardis M, Carboni JM. 2010. Insulin receptor (IR) pathway hyperactivity in IGF-IR null cells and suppression of downstream growth signaling using the dual IGF-IR/IR inhibitor, BMS-754807. Endocrinology 151:4123–4132. http://dx.doi.org/10.1210/en.2010-0032.
   PubMedGoogle Scholar
• Yamamoto Y, Hoshino Y, Ito T, Nariai T, Mohri T, Obana M, Hayata N, Uozumi Y, Maeda M, Fujio Y, Azuma J. 2008. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes. Cardiovasc Res 79:89–96. http://dx.doi.org/10.1093/cvr/cvn076.
   PubMed Web of Science ®Google Scholar
• Li J, Johnson SE. 2006. ERK2 is required for efficient terminal differentiation of skeletal myoblasts. Biochem Biophys Res Commun 345:1425–1433. http://dx.doi.org/10.1016/j.bbrc.2006.05.051.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Jones LG, Peterson CA. 1997. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts. Mol Endocrinol 11:2038–2047. http://dx.doi.org/10.1210/mend.11.13.0036.
   PubMedGoogle Scholar
• Plaisance I, Morandi C, Murigande C, Brink M. 2008. TNF-alpha increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK. Am J Physiol Endocrinol Metab 294:E241–E250. http://dx.doi.org/10.1152/ajpendo.00129.2007.
   PubMedGoogle Scholar
• Backs J, Song K, Bezprozvannaya S, Chang S, Olson EN. 2006. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 116:1853–1864. http://dx.doi.org/10.1172/JCI27438.
   PubMed Web of Science ®Google Scholar
• McKinsey TA, Zhang CL, Lu J, Olson EN. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106–111. http://dx.doi.org/10.1038/35040593.
   PubMed Web of Science ®Google Scholar
• McKinsey TA, Zhang CL, Olson EN. 2000. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci U S A 97:14400–14405. http://dx.doi.org/10.1073/pnas.260501497.
   PubMed Web of Science ®Google Scholar
• Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ. 2009. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296:C1258–C1270. http://dx.doi.org/10.1152/ajpcell.00105.2009.
   PubMed Web of Science ®Google Scholar
• Mullican SE, Zhang S, Konopleva M, Ruvolo V, Andreeff M, Milbrandt J, Conneely OM. 2007. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat Med 13:730–735. http://dx.doi.org/10.1038/nm1579.
   PubMed Web of Science ®Google Scholar
• Wu CL, Kandarian SC, Jackman RW. 2011. Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3. PLoS One 6:e16171. http://dx.doi.org/10.1371/journal.pone.0016171.
   PubMed Web of Science ®Google Scholar
• Lu J, McKinsey TA, Nicol RL, Olson EN. 2000. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci U S A 97:4070–4075. http://dx.doi.org/10.1073/pnas.080064097.
   PubMed Web of Science ®Google Scholar
• Lu J, McKinsey TA, Zhang CL, Olson EN. 2000. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell 6:233–244. http://dx.doi.org/10.1016/S1097-2765(00)00025-3.
   PubMed Web of Science ®Google Scholar
• Backs J, Worst BC, Lehmann LH, Patrick DM, Jebessa Z, Kreusser MM, Sun Q, Chen L, Heft C, Katus HA, Olson EN. 2011. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J Cell Biol 195:403–415. http://dx.doi.org/10.1083/jcb.201105063.
   PubMedGoogle Scholar
• Liu Y, Schneider MF. 2013. Opposing HDAC4 nuclear fluxes due to phosphorylation by β-adrenergic activated protein kinase A or by activity or Epac activated CaMKII in skeletal muscle fibres. J Physiol 591:3605–3623. http://dx.doi.org/10.1113/jphysiol.2013.256263.
   PubMedGoogle Scholar
• Maxwell MA, Cleasby ME, Harding A, Stark A, Cooney GJ, Muscat GE. 2005. Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J Biol Chem 280:12573–12584. http://dx.doi.org/10.1074/jbc.M409580200.
   PubMed Web of Science ®Google Scholar
• Grefte S, Kuijpers-Jagtman AM, Torensma R, Von den Hoff JW. 2007. Skeletal muscle development and regeneration. Stem Cells Dev 16:857–868. http://dx.doi.org/10.1089/scd.2007.0058.
   PubMedGoogle Scholar
• Chao LC, Bensinger SJ, Villanueva CJ, Wroblewski K, Tontonoz P. 2008. Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1. Mol Endocrinol 22:2596–2608. http://dx.doi.org/10.1210/me.2008-0161.
   PubMed Web of Science ®Google Scholar
• Tessem JS, Moss LG, Chao LC, Arlotto M, Lu D, Jensen MV, Stephens SB, Tontonoz P, Hohmeier HE, Newgard CB. 2014. Nkx6.1 regulates islet beta-cell proliferation via Nr4a1 and Nr4a3 nuclear receptors. Proc Natl Acad Sci U S A 111:5242–5247. http://dx.doi.org/10.1073/pnas.1320953111.
   PubMed Web of Science ®Google Scholar
• D'Souza DM, Al-Sajee D, Hawke TJ. 2013. Diabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells. Front Physiol 4:379. http://dx.doi.org/10.3389/fphys.2013.00379.
   PubMedGoogle Scholar
• Woo M, Isganaitis E, Cerletti M, Fitzpatrick C, Wagers AJ, Jimenez-Chillaron J, Patti ME. 2011. Early life nutrition modulates muscle stem cell number: implications for muscle mass and repair. Stem Cells Dev 20:1763–1769. http://dx.doi.org/10.1089/scd.2010.0349.
   PubMedGoogle Scholar